Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$110.31 - $140.45 $333,025 - $424,018
3,019 New
3,019 $342,000
Q4 2019

Feb 18, 2020

SELL
$36.62 - $57.29 $72,617 - $113,606
-1,983 Closed
0 $0
Q2 2019

Aug 07, 2019

BUY
$27.84 - $38.92 $55,206 - $77,178
1,983 New
1,983 $297,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Bridges Investment Management Inc Portfolio

Follow Bridges Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridges Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bridges Investment Management Inc with notifications on news.